TPN171 is a novel phosphodiesterase-5 (PDE5) inhibitor used to treat pulmonary arterial hypertension (PAH) and erectile dysfunction (ED), which currently is undergoing phase II clinical trials in China. In this single-center, single-dose, nonrandomized, and open design study, radiolabeled [14C]...
More Periodicals Find a Periodical Find a Portal Go to Product Catalog Search Terms Search within Search Advanced Search < Previous Article Next Article > Nutrition Volume 13, Issue 1, Page 79, January 1997 Switch to Standard ViewSwitch to Enhanced View...
Portal Automation Engineering Framework Software Development & IoT Capital Embedded Software, Networks & Tools Insights Hub Industrial IoT for Digital Twins Mendix Low-Code Application Development PLM Components Software Development Toolkits Electrical Systems Capital E/E Systems Development Solid Edge ...
Portal Automation Engineering Framework Software Development & IoT Capital Embedded Software, Networks & Tools Insights Hub Industrial IoT for Digital Twins Mendix Low-Code Application Development PLM Components Software Development Toolkits Electrical Systems Capital E/E Systems Development Solid Edge ...